About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

Biopreservation and Biobanking

Editor-in-Chief: Jim Vaught, PhD

ISSN: 1947-5535 • Published Bimonthly • Online ISSN: 1947-5543

Current Volume: 10

Latest Impact Factor* is 1.412
*2010 Journal Citation Reports® published by Thomson Reuters, 2011

NIH / HHMI /Wellcome Trust Policies

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors.  Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge.  Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Authors who would like their papers to be posted on Liebertpub.com immediately without this embargo period will have the option to make their articles available free on line via Liebert Open Option for a one-time fee of $3,200. This fee also makes the article free in perpetuity on the Liebertpub.com site. If you've received NIH funding we will also immediately deposit your paper to PMC.

Authors Funded by HHMI and Wellcome Trust: Please follow the instructions for Liebert Open Option above.

If you have any questions, please contact AuthorServices@liebertpub.com

Recommended Publications

You may be interested in the following publications:

    DNA and Cell Biology

    DNA and Cell Biology

    Combining mechanistic and clinical studies from multiple systems in a single resource, the Journal delivers authoritative, peer-reviewed reporting on the latest research in the field of molecular biology.

    Advances in Tissue Engineering, Volume 1: Angiogenesis

    Advances in Tissue Engineering, Volume 1: Angiogenesis

    The essential book series highlighting important advances in specific areas of tissue engineering development. Volume 1 addresses angiogenesis and vasculogenesis, focusing on the process of new blood vessel development.

    Cellular Reprogramming

    Cellular Reprogramming

    formerly Cloning and Stem Cells

    Cutting-edge techniques and the latest high-quality research on the etiology, development, and potential treatment of various diseases through reprogramming cellular mechanisms.

    Hybridoma

    Hybridoma

    The essential journal for scientists and clinicians in the fields of molecular immunology and immunopathology, and for all those applying molecular immunological methods for experimental and therapeutic purposes.

    ASSAY and Drug Development Technologies

    ASSAY and Drug Development Technologies

    This authoritative, rapidly peer-reviewed journal features original articles, application-oriented technology reviews, and reports in methodology and technology application.

Browse All Publications »